Literature DB >> 9241686

Weighing the risks and the benefits: a call for the empirical assessment of perceived teratogenic risk.

J E Polifka1, E M Faustman, N Neil.   

Abstract

Pregnant women are often faced with complex decisions about whether to undergo medical treatment or continue working in an occupational setting that is permeated with hazardous chemicals. The task for these women is to weigh the benefits of these activities against the potential risks that they may have on the developing embryo. Scientific uncertainty with respect to the teratogenicity of drugs and chemicals in humans leaves health care professionals and their pregnant patients with little predictive information. Cognitive research has shown that it is difficult for people to make complex decisions, particularly when the risks are uncertain. Although the problems inherent in counseling pregnant women regarding teratogenic risk are not new, little time has been devoted to the empiric assessment of how people perceive teratogenic risk and how teratogenic risk information can be best communicated. This article explores the variables that have been found, through psychometric research, to influence people's perception of risk and how cognitive models derived from these studies may be applicable to teratogen information counseling. Understanding the variables that shape the perception of teratogenic risk can help health care professionals improve how they communicate these risks to their patients. Improved teratogenic risk communication will result in better management of pregnancies and reduction of costly litigation that ensues when risks are not properly communicated and understood.

Entities:  

Mesh:

Year:  1997        PMID: 9241686     DOI: 10.1016/s0890-6238(97)00010-5

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  6 in total

1.  Birth defects, causal attributions, and ethnicity in the national birth defects prevention study.

Authors:  Amy P Case; Marjorie Royle; Angela E Scheuerle; Suzan L Carmichael; Karen Moffitt; Tunu Ramadhani
Journal:  J Genet Couns       Date:  2014-03-29       Impact factor: 2.537

2.  Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.

Authors:  Agnes Kant; Loes de Vries; Leàn Rolfes
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

3.  Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.

Authors:  Sofia Frost Widnes; Jan Schjøtt; Geir Egil Eide; Anne Gerd Granas
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

4.  A descriptive analysis of calls to the NSW Teratogen Information Service regarding use of anti-infectives during pregnancy.

Authors:  Helen E Ritchie; Elizabeth Hegedus; Joanne Ma; Debra Kennedy
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

5.  Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area.

Authors:  Christine Damase-Michel; Juliette Pichereau; Atul Pathak; Isabelle Lacroix; Jean Louis Montastruc
Journal:  Pharm Pract (Granada)       Date:  2008-03-10

6.  Prescribing antidepressants and anxiolytic medications to pregnant women: comparing perception of risk of foetal teratogenicity between Australian Obstetricians and Gynaecologists, Speciality Trainees and upskilled General Practitioners.

Authors:  Summer Williams; George Bruxner; Emma Ballard; Alka Kothari
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-14       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.